WNT3A and colorectal cancer: The Wnt activity in the Wnt3a/Rspo-treated SK-N-BE(2)-C and SH-SY5Y cells was comparable to the colorectal cancer line HCT116 which has an activating point-mutation of β-catenin and constitutive Wnt activation (Figure 2A).